E
Genetic Technologies Limited GENE
$0.765 -$0.015-1.92%
Recommendation
Sell
Prev Close
$0.765
Volume
22,667
Avg Vol (90D)
11,561
Market Cap
$3.60M
Dividend & Yield
--
52-Week Range
$0.6666 - $3.59
P/E (TTM)
--
EPS (TTM)
-$0.0611
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Genetic Technologies (NASDAQ:GENE) and#038; Acumen Pharmaceuticals (NASDAQ:ABOS) Financial Survey
12/8/2024 - Ticker Report
Genetic Technologies Defers Reports Amid Administration
12/1/2024 - TipRanks Financial Blog
Genetic Technologies Halts Offers, Returns Funds Amid Compliance Scrutiny
11/29/2024 - TipRanks Financial Blog
Genetic Technologies Enters Voluntary Administration
11/20/2024 - TipRanks Financial Blog
Genetic Technologies Extends Securities Offer Deadline
11/1/2024 - TipRanks Financial Blog
Genetic Technologies Extends Entitlement Offer Deadline
11/1/2024 - TipRanks Financial Blog
Genetic Technologies Extends Offer and Suspends Trading
11/1/2024 - TipRanks Financial Blog
Genetic Technologies Extends Voluntary Suspension for Strategic Moves
10/24/2024 - TipRanks Financial Blog
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
10/11/2024 - Accesswire
Genetic Technologies Limited (NASDAQ:GENE) Short Interest Update
10/10/2024 - Ticker Report
Genetic Technologies Secures R&D Tax Refund
10/8/2024 - TipRanks Financial Blog
Armistice Capital LLC Takes Position in Genetic Technologies Limited (NASDAQ:GENE)
9/28/2024 - Ticker Report
Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2
9/23/2024 - Globe Newswire
Genetic Technologies Extends Share Offer Period
9/17/2024 - TipRanks Financial Blog
Genetic Technologies invited to join CancerIQ online platform
9/11/2024 - The Fly
Genetic Technologies Invited to Join Prestigious CancerIQ Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
9/11/2024 - Globe Newswire
Genetic Technologies Embraces Capital-Light Model
8/30/2024 - TipRanks Financial Blog
Genetic Technologies Reports Increased Annual Loss
8/30/2024 - TipRanks Financial Blog
Head-To-Head Survey: Genetic Technologies (NASDAQ:GENE) and Vir Biotechnology (NASDAQ:VIR)
8/22/2024 - Ticker Report
Genetic Technologies announces global launch of geneType on EasyDNA platform
8/15/2024 - The Fly
Genetic Technologies Announces Global Launch of geneType on Wholly Owned EasyDNA platform
8/15/2024 - Globe Newswire
Genetic Technologies Launches Exclusive Entitlement Offer
8/12/2024 - TipRanks Financial Blog
Genetic Technologies Launches Shareholder Entitlement Offer
8/12/2024 - TipRanks Financial Blog
Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on August 15
8/9/2024 - Globe Newswire
Genetic Technologies intends to transition to capital light operations model
7/26/2024 - The Fly
Income Statement
Total Revenue (TTM)
$6.34M
EBITDA (TTM)
-$6.60M
EBIT (TTM)
-$6.95M
Net Income (TTM)
-$7.88M
Balance Sheet
Total Assets (Q)
$4.13M
Total Debt (Q)
$583.90K
Total Liabilities (Q)
$2.91M
Book Value Per Share (Q)
$0.0092
Cash Flow
Cash from Operations (TTM)
-$6.35M
Cash from Investing (TTM)
$75.20K
Cash from Financing (TTM)
$1.86M
Net Change in Cash (TTM)
-$4.48M
Filings
Filing Date
Monday, September 30, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Feb 17 and 21 (est)
Price History
Loading...
Beta
1.02
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Oct 02, 2024 - $0.6666
52-week High
Apr 12, 2024 - $3.59
Valuation
Market Cap
$3.60M - Nano Cap
Enterprise Value
$3.50M
Price/Sales (TTM)
18.00
Price/Book (Q)
83.15
Dividends and Shares
Shares Outstanding
149.02M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
genetype.com
Phone Number
61 3 8412 7000
Address
321 Chapel Street
Level 1 - Suite 7
Prahran, VIC 3181
Country
Australia
Year Founded
1987
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the... more
NASDAQ 10/16/2024 4:59PM Eastern Quotes delayed
Weiss Ratings